查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1886725

全球子宫内避孕器市场

Intrauterine Devices
出版日期: | 出版商: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计2030年，全球子宫内避孕器市场规模将达49亿美元。

2024年全球子宫内避孕器市场规模估计为39亿美元，预计2030年将达49亿美元，在分析期间（2024-2030年）内复合年增长率（CAGR）为3.8%。本报告分析的细分市场之一－含激素黄体素子宫内避孕器，预计复合年增长率为3.4%，到分析期末将达34亿美元。不含激素的含铜子宫内避孕器细分市场预计在分析期间内复合年增长率为4.8%。

美国市场规模估计为11亿美元，而中国市场预计将以3.6%的复合年增长率成长。

据估计，2024年美国子宫内避孕器市场规模将达11亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到7.766亿美元，在2024年至2030年的分析期内，年复合成长率（CAGR）为3.6%。其他值得关注的区域市场分析包括日本和加拿大，预计在分析期间内，两国的年复合成长率分别为3.5%和3.2%。在欧洲，德国的年复合成长率预计约为3.9%。

全球子宫内避孕器市场－主要市场趋势与驱动因素摘要

什么是子宫内避孕器？为什么它是一种流行的长期避孕方法？

子宫内避孕器（IUD）是一种小型T形避孕装置，放置于子宫内以防止怀孕。其高效能、​​便捷和可逆性使其成为一种广受欢迎的长期避孕方法。子宫内避孕器分为含激素型和非激素型；前者释放少量黄体素以抑制排卵，后者通常由铜製成，可创造不利于精子生存的环境。由于子宫内避孕器可避孕数年，因此对于寻求长期、便捷避孕方式的女性来说，它是一个极具吸引力的选择。此外，子宫内避孕器可随时取出，迅速恢復生育能力，更提升了其便利性。随着人们对子宫内避孕器益处的认识不断提高，它正迅速成为全球女性首选的避孕方法。

科技进步如何影响子宫内避孕器市场？

技术创新正对子宫内避孕器市场产生重大影响，尤其是在避孕器设计、材料和安全功能方面的创新。现代子宫内避孕器旨在提高舒适度和易置性，有些型号体积更小，并采用更柔软的材料，以减少置入过程中的不适感。激素释放型子宫内避孕器的进步促成了低剂量激素缓释型避孕器的研发，这些节育器可在更长时间内释放更低剂量的激素，从而在保持有效性的同时降低副作用风险。此外，安全性更高的子宫内避孕器的推出，例如最大限度地降低穿孔和排放的风险，也促进了其普及。这些创新使子宫内避孕器更容易获得，并受到更多女性的青睐，推动了市场成长。

避孕保健领域对子宫内避孕器的需求不断增长，背后原因是什么？

子宫内避孕器在避孕护理领域的需求不断增长，主要源于人们对无需持续维护的长期可靠避孕方式日益增长的需求。随着女性寻求每日口服避孕药和注射、贴片等短期避孕方法的替代方案，子宫内避孕器提供了一种高效且几乎无需后续维护的解决方案。此外，人们对子宫内避孕器长期健康益处的认识不断提高，例如不影响母乳哺育以及可能降低某些癌症的风险，也推动了子宫内避孕器的需求成长。同时，全球延后生育的趋势以及计划生育服务的日益普及也促进了子宫内避孕器的普及。随着越来越多的女性优先考虑有效、便捷且可逆的避孕方式，预计子宫内避孕器的需求将持续成长。

哪些因素正在推动子宫内避孕器市场的成长？

子宫内避孕器市场的成长受多种因素驱动，包括技术进步、消费者偏好变化以及避孕选择的日益丰富。其中一个关键驱动因素是子宫内避孕器设计和材料的改进，这些改进使避孕器更加舒适、安全和有效，从而吸引了更多女性的青睐。此外，人们对长期、便利的避孕方法的需求不断增长也是推动市场成长的偏好之一。子宫内避孕器为每日避孕和短期避孕方法提供了可靠的替代方案。同时，计划生育服务的普及以及全球对生殖健康和权利的倡议也促进了市场成长，使更多女性能够获得避孕服务。此外，人们对子宫内避孕器健康益处的认识不断提高，例如其降低某些癌症风险的能力以及其对各类女性的适用性，也推动了子宫内避孕器的普及。随着这些趋势的持续发展，对有效、安全、便捷的避孕解决方案的需求预计将推动子宫内避孕器市场持续成长。

部分：

依类型（含荷尔蒙黄体素的子宫内避孕器、不含荷尔蒙的含铜子宫内避孕器）、年龄层（15-24岁、25-34岁、35-44岁、45岁以上）及用途（医院、诊所、社区健康中心、其他用途）分类。

受访公司范例

  • Allergan PLC
  • ANI Pharmaceuticals, Inc.
  • Bayer AG
  • Besins Healthcare（Monaco）
  • CooperSurgical, Inc.
  • Eurogine, SL
  • HLL Lifecare Ltd.
  • HRA Pharma
  • OCON Medical Ltd.
  • Pregna International Ltd.
  • SMB Corporation
  • Teva Pharmaceutical Industries Ltd.

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具，改变您分析市场和竞争情报的方式。

Market Glass, Inc. 并没有采用典型的 LLM 或产业专用的SLM 方法，而是建立了一个由世界各地领域专家精心策划的内容库，其中包括影片转录、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

在最新发布的报告中，Market Glass, Inc. 将关税对地理市场的影响纳入考量，并根据公司总部所在地、製造地以及进出口（成品和OEM产品）情况，预测企业竞争地位的变化。这种复杂多变的市场现实会从多个方面影响竞争对手，包括增加销货成本、降低盈利和重组供应链，同时也会影响微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲
  • 亚太地区
  • 世界其他地区

第四章 竞赛

简介目录
Product Code: MCP12831

Global Intrauterine Devices Market to Reach US$4.9 Billion by 2030

The global market for Intrauterine Devices estimated at US$3.9 Billion in the year 2024, is expected to reach US$4.9 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Hormonal Progestogen-Releasing IUD, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.4 Billion by the end of the analysis period. Growth in the Nonhormonal Copper-Containing IUD segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 3.6% CAGR

The Intrauterine Devices market in the U.S. is estimated at US$1.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$776.6 Million by the year 2030 trailing a CAGR of 3.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Intrauterine Devices Market - Key Trends & Drivers Summarized

What Are Intrauterine Devices and Why Are They a Popular Choice for Long-Term Contraception?

Intrauterine devices (IUDs) are small, T-shaped contraceptive devices that are inserted into the uterus to prevent pregnancy. They are a popular choice for long-term contraception due to their high effectiveness, convenience, and reversibility. IUDs can be hormonal or non-hormonal, with the former releasing small amounts of progestin to prevent ovulation and the latter, typically made of copper, creating an environment that is toxic to sperm. IUDs provide protection against pregnancy for several years, making them an attractive option for women seeking long-term, hassle-free contraception. Their ability to be removed at any time, allowing for a quick return to fertility, further enhances their appeal. As awareness of the benefits of IUDs increases, they are becoming a preferred contraceptive method among women worldwide.

How Are Technological Advancements Shaping the Intrauterine Devices Market?

Technological advancements are significantly shaping the intrauterine devices market, particularly through innovations in device design, materials, and safety features. Modern IUDs are being designed to offer improved comfort and ease of insertion, with some models featuring smaller sizes and flexible materials to reduce discomfort during placement. Advances in hormonal IUDs have led to the development of devices that release lower doses of hormones over longer periods, reducing the risk of side effects while maintaining efficacy. Additionally, the introduction of IUDs with enhanced safety profiles, such as devices that minimize the risk of perforation and expulsion, is contributing to increased adoption. These innovations are making IUDs more accessible and appealing to a broader range of women, driving growth in the market.

Why Is There an Increasing Demand for Intrauterine Devices in Contraceptive Care?

The demand for intrauterine devices is increasing in contraceptive care due to the growing emphasis on long-term, reliable, and low-maintenance birth control options. As women seek alternatives to daily oral contraceptives and short-term methods like injections or patches, IUDs offer a highly effective solution that requires little ongoing maintenance. The rising awareness of the long-term health benefits of IUDs, such as their non-interference with breastfeeding and their potential to reduce the risk of certain cancers, is also driving demand. Additionally, the global trend towards delaying childbirth and the increasing availability of family planning services are contributing to the growing popularity of IUDs. As more women prioritize effective, convenient, and reversible contraception, the demand for IUDs is expected to continue to rise.

What Factors Are Driving the Growth in the Intrauterine Devices Market?

The growth in the intrauterine devices market is driven by several factors related to technological advancements, changing consumer preferences, and the increasing availability of contraceptive options. One of the primary drivers is the advancement in IUD design and materials, which has improved the comfort, safety, and efficacy of these devices, making them more attractive to a wider range of women. The growing preference for long-term, low-maintenance contraception is also fueling demand, as IUDs offer a reliable alternative to daily or short-term methods. The increasing availability of family planning services and the global push for reproductive health and rights are further contributing to market growth, as more women gain access to contraceptive options. Additionally, the rising awareness of the health benefits of IUDs, such as their potential to reduce the risk of certain cancers and their suitability for a wide range of women, is driving adoption. As these trends continue to evolve, the intrauterine devices market is expected to experience sustained growth, driven by the need for effective, safe, and convenient contraceptive solutions.

SCOPE OF STUDY:

The report analyzes the Intrauterine Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Hormonal Progestogen-Releasing IUD, Nonhormonal Copper-Containing IUD); Age Group (15 - 24, 25 - 34, 35 - 44, Above 44); End-Use (Hospitals, Clinics, Community Healthcare Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • Allergan PLC
  • ANI Pharmaceuticals, Inc.
  • Bayer AG
  • Besins Healthcare (Monaco)
  • CooperSurgical, Inc.
  • Eurogine, S.L
  • HLL Lifecare Ltd.
  • HRA Pharma
  • OCON Medical Ltd.
  • Pregna International Ltd.
  • SMB Corporation
  • Teva Pharmaceutical Industries Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Intrauterine Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Long-Acting Reversible Contraception Spurs Adoption of Intrauterine Devices (IUDs)
    • Advancements in IUD Technology Propel Innovation in Contraceptive Solutions
    • Shift Towards Non-Hormonal and Hormonal IUDs Expands Market Opportunities
    • Increasing Use of IUDs in Family Planning Programs Globally
    • Role of IUDs in Reducing Unintended Pregnancies
    • Advancements in IUD Insertion Techniques and Device Safety Propel Market Growth
    • Emerging Markets Present New Opportunities for IUD Manufacturers
    • Rise in Demand for Targeted Temperature Management Spurs Adoption of Intravascular Temperature Management Devices
    • Advancements in Cooling and Heating Technology Propel Innovation in Temperature Management
    • Shift Towards Minimally Invasive Temperature Regulation Expands Market Opportunities
    • Increasing Use of Intravascular Temperature Management in Post-Cardiac Arrest Patients
    • Growing Importance of Hypothermia Induction in Trauma and Surgery
    • Advancements in Catheter-Based Cooling and Warming Systems Propel Market Growth
    • Push for Cost-Effective and Efficient Temperature Management Solutions
    • Role of Intravascular Temperature Management in Improving Patient Outcomes
    • Growing Focus on Patient Safety and Reducing Complications
    • Integration of Temperature Management Devices with Advanced Monitoring Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intrauterine Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intrauterine Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Intrauterine Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Intrauterine Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hormonal Progestogen-Releasing IUD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Hormonal Progestogen-Releasing IUD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Hormonal Progestogen-Releasing IUD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Nonhormonal Copper-Containing IUD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Nonhormonal Copper-Containing IUD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Nonhormonal Copper-Containing IUD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for 15 - 24 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for 15 - 24 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for 15 - 24 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for 25 - 34 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for 25 - 34 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for 25 - 34 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for 35 - 44 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for 35 - 44 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for 35 - 44 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Above 44 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Above 44 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Above 44 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Community Healthcare Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Community Healthcare Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Community Healthcare Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Intrauterine Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Intrauterine Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Intrauterine Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Europe 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Intrauterine Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Asia-Pacific 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Intrauterine Devices by Type - Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of World 15-Year Perspective for Intrauterine Devices by Type - Percentage Breakdown of Value Sales for Hormonal Progestogen-Releasing IUD and Nonhormonal Copper-Containing IUD for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Intrauterine Devices by Age Group - 15 - 24, 25 - 34, 35 - 44 and Above 44 Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Intrauterine Devices by Age Group - Percentage Breakdown of Value Sales for 15 - 24, 25 - 34, 35 - 44 and Above 44 for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Intrauterine Devices by End-Use - Hospitals, Clinics, Community Healthcare Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for Intrauterine Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Clinics, Community Healthcare Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION